You just read:

Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy

News provided by

Jazz Pharmaceuticals plc

28 Nov, 2016, 21:05 GMT